Veru Inc. ( VERU) - Key Metrics
VERU Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0 | -$0.30 | -$0.24 | -$0.24 |
| 2026Q2 | $0 | -$0.13 | -$0.41 | -$0.41 |
| 2026Q1 | $0 | -$0.26 | -$0.30 | -$0.30 |
| 2025Q4 | $0 | $0.10 | -$0.37 | -$0.37 |
| 2025Q3 | $0 | -$0.50 | -$0.37 | -$0.37 |
VERU Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -2.61 |
| 2026Q2 | 0% | -4.25 |
| 2026Q1 | 0% | -2.06 |
| 2025Q4 | 0% | 10.67 |
| 2025Q3 | 0% | -2.91 |
VERU
Price: $2.59
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.61 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.1 million
Ebitda: -7.3 millionMarket Capitalization: 46.5 million